Artificial Sweeteners Linked to Accelerated Cognitive Decline in Adults Under 60
A groundbreaking 2025 study published in Neurology, the esteemed journal of the American Academy of Neurology, has revealed a concerning association between the daily consumption of artificial sweeteners and a significantly steeper cognitive decline in adults under the age of 60. The research, which followed over 12,000 participants for nearly a decade, suggests that even a modest intake, equivalent to one diet soda per day, can accelerate cognitive aging by approximately 1.6 years in this demographic. This finding challenges the long-held perception of artificial sweeteners as harmless, calorie-free alternatives, prompting a re-evaluation of their impact on brain health over time.
The study meticulously examined the consumption of common artificial sweeteners, including aspartame, saccharin, acesulfame-K, erythritol, sorbitol, and xylitol. These are ubiquitous ingredients found in a vast array of products marketed as "sugar-free," "light," or "better for you," ranging from diet beverages and energy drinks to protein bars, yogurts, and tabletop sweeteners. While the debate surrounding artificial sweeteners and their effects on weight management and blood sugar levels has been ongoing for decades, this latest research shifts the focus to their potential neurocognitive consequences.
The implications of these findings are particularly pronounced for the under-60 population, a demographic actively seeking healthier lifestyle choices, often incorporating sugar substitutes into their daily routines. The study’s lead author, Dr. Claudia Kimie Suemoto, an associate professor of geriatrics at the University of São Paulo, emphasized the potential long-term ramifications of midlife dietary exposures. "This suggests that midlife dietary exposures, decades before cognitive symptoms emerge, may carry life-long consequences for brain health," noted Dr. Thomas Holland, an instructor at Rush University’s Institute for Healthy Aging, in an accompanying editorial. This perspective suggests that the foundational work for future cognitive decline may be laid much earlier in life than previously understood.
The Foundation of the Study: A Large-Scale Prospective Investigation
The research underpinning these alarming conclusions is the Brazilian Longitudinal Study of Adult Health (BLSA), a comprehensive, prospective study that tracked the cognitive health of 12,772 adults. Participants, with an average age of 52 at the study’s commencement, underwent standardized cognitive assessments every four years across three study waves spanning from 2008 to 2019. This extensive period and large cohort size make it the most significant and longest-running prospective study to date investigating the intricate relationship between artificial sweetener consumption and cognitive decline.
To estimate sweetener intake, researchers utilized food frequency questionnaires completed by participants at the study’s inception. These questionnaires captured detailed information about dietary habits, allowing for the calculation of both combined and individual consumption of seven artificial sweeteners, including the sugar alcohols erythritol, sorbitol, and xylitol. Cognitive function was then systematically evaluated through six assessments over the study’s duration, focusing on key areas such as memory, language, and overall thinking skills. A critical component of these assessments was verbal fluency, a measure of the ability to quickly retrieve and generate words, which is known to be an early indicator of cognitive impairment.
Quantifying the Cognitive Impact: A Dose-Dependent Relationship
The study’s findings revealed a clear, dose-dependent relationship between artificial sweetener consumption and the rate of cognitive decline. Participants under 60 who reported the highest total intake of artificial sweeteners exhibited a 62% faster decline in thinking and memory skills compared to those who consumed the least. This accelerated decline was quantified as being equivalent to approximately 1.6 years of additional cognitive aging.
The intake levels that correlated with this accelerated decline were not extreme. The lowest intake group averaged around 20 mg of artificial sweeteners per day, while the highest intake group consumed approximately 191 mg daily. This latter amount is notably equivalent to the aspartame content found in a single can of diet soda, according to the research team. This comparison provides a tangible and relatable benchmark for the average consumer.
Even moderate consumption demonstrated a measurable impact. Individuals who consumed moderate amounts of sugar substitutes experienced a 35% faster rate of brain decline than the lowest intake group, an effect comparable to about 1.3 years of accelerated aging. These figures underscore that even seemingly moderate daily habits can contribute to a cumulative impact on cognitive function over time.
The Spectrum of Sweeteners Under Scrutiny
The study identified several artificial sweeteners individually associated with faster cognitive decline, particularly affecting memory. Aspartame, saccharin, acesulfame-K, erythritol, sorbitol, and xylitol were all implicated. Only tagatose was not found to be linked with cognitive decline in this research. The widespread presence of these sweeteners in everyday food items highlights the pervasive nature of their potential influence. They are primarily found in ultra-processed foods, a category that includes flavored waters, sodas, energy drinks, yogurts, and low-calorie desserts.
The U.S. Food and Drug Administration (FDA) has approved six high-intensity sweeteners as food additives: saccharin, aspartame, acesulfame-K, sucralose, neotame, and advantame. The inclusion of sugar alcohols like sorbitol, erythritol, and xylitol in the study is particularly relevant, as these are often found in products that consumers might not immediately associate with artificial sweeteners, such as sugar-free gums, mints, and some dried fruits. Sorbitol, in particular, registered the highest mean daily consumption among all sweeteners studied in the BLSA cohort, averaging 64 mg per day, underscoring its significant presence in the typical diet.
The Under-60 Effect: A Critical Age Window
A particularly striking aspect of the study’s findings pertains to age. When the data was analyzed by age group, a significant pattern emerged: individuals under 60 who consumed the highest amounts of artificial sweeteners showed accelerated declines in verbal fluency and overall cognitive function. This association was not observed in participants over the age of 60.
This age-specific effect leads to a crucial hypothesis: that dietary exposures during midlife may have lasting consequences for brain health, even before overt symptoms of cognitive decline become apparent in later years. The brain changes that eventually manifest as memory loss or cognitive slowing in older age may be significantly influenced by dietary habits formed in one’s 40s and 50s. This reframes the understanding of risk, suggesting that interventions aimed at preserving cognitive function may need to target younger populations and their dietary choices.
The link between artificial sweetener consumption and cognitive decline was even more pronounced in individuals with diabetes. This subgroup often relies heavily on these sweeteners as sugar substitutes to manage blood glucose levels. "While we found links to cognitive decline for middle-aged people both with and without diabetes, people with diabetes are more likely to use artificial sweeteners as sugar substitutes," Dr. Suemoto elaborated. This highlights a complex interplay of factors for individuals managing chronic conditions and raises questions about the optimal dietary strategies for this population.
Potential Mechanisms: Neuroinflammation and Gut-Brain Axis Disruption
While the study established a strong association, it is important to note that it was observational, meaning it identified correlations rather than proving direct causation. The precise biological mechanisms by which artificial sweeteners might affect the brain remain an area of active research. However, researchers have proposed several plausible pathways.
One leading hypothesis involves neuroinflammation. Animal studies have suggested that certain artificial sweeteners, such as aspartame, can trigger inflammatory responses within the brain. Neuroinflammation is increasingly recognized as a significant contributor to neurodegenerative processes and cognitive decline.
Another potential mechanism relates to the disruption of the gut-brain axis. Sugar alcohols like erythritol and sorbitol have been implicated in altering the composition of gut microbiota, the complex community of microorganisms residing in the digestive tract. These changes can, in turn, affect the blood-brain barrier, a protective shield that regulates the passage of substances into the brain. The gut-brain axis, a bidirectional communication pathway between the digestive system and the brain, plays a crucial role in cognitive health. Emerging evidence suggests that non-caloric sweeteners can interact with physiological processes, altering gut bacteria and influencing neural circuits that regulate feeding behaviors and mood. Disrupting this delicate balance can alter the chemical signals the brain receives, with consequences extending beyond mere digestion.
It is important to acknowledge that animal studies often involve very high doses of sweeteners, which may not directly translate to the typical human consumption levels. Therefore, further research, particularly in human models, is deemed essential to elucidate these mechanisms.
Broader Implications and Public Health Considerations
The findings of this study carry significant implications for public health recommendations and consumer awareness. The consistent link between higher artificial sweetener intake and faster cognitive slippage, even without proving causation, warrants serious consideration. The study’s focus on verbal fluency as an early indicator of cognitive decline is particularly noteworthy. This ability, the rapid retrieval of words from memory, is clinically used to detect early cognitive impairment and often precedes broader memory problems by several years.
The study also acknowledges its limitations. Not all artificial sweeteners were comprehensively assessed, and dietary information was self-reported, which can be subject to recall bias. Consumers may underestimate or misremember their intake, potentially leading to an underestimation of the actual exposure differences between study groups. Nevertheless, these are standard limitations in dietary research, and the robustness of the findings across a large cohort suggests a genuine underlying association.
The research also indirectly supports a growing body of evidence linking ultra-processed foods to adverse health outcomes. Studies on ultra-processed foods consistently demonstrate their association with measurable changes across multiple organ systems, including the brain. This underscores a broader dietary trend that may be contributing to cognitive decline.
Navigating the Information: What Consumers and Experts Advise
In response to these findings, experts are urging a balanced approach rather than immediate panic. Dr. Suemoto advised that "more research is needed to confirm our findings and to investigate if other refined sugar alternatives, such as applesauce, honey, maple syrup or coconut sugar, may be effective alternatives." This cautious stance reflects the scientific process, where one study, even a significant one, contributes to a larger body of evidence.
The prevailing sentiment is that the assumption of zero risk associated with zero calories is becoming increasingly difficult to sustain. The practical takeaway for consumers is to enhance awareness of ingredient lists. Many products contain multiple sweeteners, and their combined intake can accumulate rapidly. Relying on front-of-pack claims like "sugar-free" without scrutinizing the ingredient list can lead to a higher overall consumption of artificial sweeteners than anticipated.
For individuals with diabetes who rely on artificial sweeteners for blood sugar management, the findings necessitate a discussion with their healthcare providers. The risk-benefit calculation for this group is more complex, and unilateral changes to diet could introduce new challenges.
For the general population, the evidence suggests a move towards reducing routine reliance on artificially sweetened low-calorie products. Prioritizing whole foods, such as fruits, which provide natural sweetness alongside essential fiber, antioxidants, and micronutrients, is a recommended strategy. Intentional and moderate use of natural sweeteners like honey or maple syrup, when incorporated into a balanced diet, is likely to have a different impact than the habitual consumption of diet sodas or sugar-free snacks throughout the day. The goal is not necessarily complete abstinence but a reduction in the pervasive daily exposure that this research suggests may have a cumulative and significant impact on long-term cognitive health.
